The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma-Reference-Cited by-同舟云学术

The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma

Published:2021-05 Issue:5 Volume:9 Page:2093-2096.e1
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Hearn Andrew P.,Kavanagh Joanne,d’Ancona Grainne,Roxas Cris,Green Linda,Thomson Louise,Fernandes Marianna,Kent Brian D.,Dhariwal Jaideep,Nanzer Alexanda M.,Jackson David J.

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference9 articles.

1. Real-world effectiveness and the characteristics of a “super-responder” to mepolizumab in severe eosinophilic asthma;Kavanagh;Chest,2020

2. Real world effectiveness of benralizumab in severe eosinophilic asthma;Kavanagh;Chest,2021

3. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma;Castro;N Engl J Med,2018

4. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial;Pavord;Lancet,2012

5. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases;Schmid-Grendelmeier;J Immunol,2002

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Role of Nitric Oxide in Lower Airway Diseases: Insights and Real-world Application;Current Medicinal Chemistry;2024-11

2. Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype;New England Journal of Medicine;2024-09-09

3. Biologics in Asthma;Immunology and Allergy Clinics of North America;2024-09

4. Biomarkers in asthma, potential for therapeutic intervention;Journal of Asthma;2024-06-13

5. Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme;European Respiratory Journal;2024-04-04